HCM
Hodges Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,800
| Closed | -$415K | – | 221 |
|
|
2022
Q3 | $415K | Buy |
7,800
+2,650
| +51% | +$141K | 0.07% | 160 |
|
|
2022
Q2 | $300K | Sell |
5,150
-162,562
| -97% | -$9.47M | 0.03% | 190 |
|
|
2022
Q1 | $12.8M | Sell |
167,712
-238
| -0.1% | -$18.2K | 1.02% | 30 |
|
|
2021
Q4 | $10.1M | Buy |
+167,950
| New | +$10.1M | 0.73% | 48 |
|
|
2021
Q2 | – | Sell |
-75,245
| Closed | -$5.27M | – | 243 |
|
|
2021
Q1 | $5.27M | Buy |
+75,245
| New | +$5.27M | 0.73% | 48 |
|
|
2017
Q4 | – | Sell |
-7,000
| Closed | -$263K | – | 262 |
|
|
2017
Q3 | $263K | Buy |
7,000
+2,000
| +40% | +$75.1K | 0.02% | 234 |
|
|
2017
Q2 | $238K | Sell |
5,000
-140,000
| -97% | -$6.66M | 0.01% | 243 |
|
|
2017
Q1 | $6.61M | Sell |
145,000
-14,000
| -9% | -$638K | 0.33% | 82 |
|
|
2016
Q4 | $5.14M | Buy |
+159,000
| New | +$5.14M | 0.24% | 90 |
|
|
2015
Q2 | – | Sell |
-295,294
| Closed | -$26.2M | – | 307 |
|
|
2015
Q1 | $26.2M | Buy |
295,294
+1,034
| +0.4% | +$91.9K | 1% | 30 |
|
|
2014
Q4 | $26.1M | Buy |
294,260
+30,480
| +12% | +$2.7M | 1.06% | 24 |
|
|
2014
Q3 | $25.6M | Buy |
263,780
+33,530
| +15% | +$3.25M | 1.06% | 20 |
|
|
2014
Q2 | $21.2M | Buy |
230,250
+915
| +0.4% | +$84.1K | 0.99% | 22 |
|
|
2014
Q1 | $16.1M | Sell |
229,335
-5,890
| -3% | -$412K | 0.94% | 27 |
|
|
2013
Q4 | $13.5M | Sell |
235,225
-77,005
| -25% | -$4.43M | 0.97% | 26 |
|
|
2013
Q3 | $15M | Buy |
+312,230
| New | +$15M | 1.3% | 12 |
|